Allred Capital Management, LLC Vertex Pharmaceuticals Inc Transaction History

Allred Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$187.49 - $221.1 $132,555 - $156,317	-707 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$207.02 - $241.31 $66,867 - $77,943	323 Added 84.11%	707 $151,000
Q1 2020 Apr 17, 2020	BUY	$199.77 - $247.81 $4,794 - $5,947	24 Added 6.67%	384 $91.4 Million
Q4 2019 Jan 13, 2020	BUY	$166.71 - $223.91 $60,015 - $80,607	360 New	360 $78,000

1,625

222M

1.35M

1.49M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $125B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Allred Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Allred Capital Management, LLC with notifications on news.